Freya Biosciences
Freya Biosciences is a biotech company in Copenhagen, Denmark, founded in 2020. It has raised $49.2M across 2 rounds, most recently an $11.2M Seed in November 2024.
Driving immune-mediated therapeutic innovation for women
- Headquarters
- Copenhagen
- Employees
- 11–50
- Founded
- 2020
- Business Model
- B2B
- Website
- freyabiosciences.com
- Total Funding
- $49.2M
- Last Round
- $11.2M SeedNov 2024
- Rounds
- 2
Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.
Indexed holds 2 funding rounds and 5 investors for this company. The full record is or through the API.
About
Freya Biosciences is a clinical-stage immunology company headquartered in Copenhagen, Denmark, developing disease-modifying microbial immunotherapies targeting inflammation and immune dysregulation in conditions affecting women. The company's lead programs focus on the underlying immune mechanisms driving infertility, preterm birth, and endometriosis — conditions where current treatments address only symptoms. Freya's scientific approach leverages the microbiome and endocannabinoid system to restore healthy immune function in the reproductive tract, with a Phase 2 pipeline backed by investors including Sofinnova Partners, the Bill & Melinda Gates Foundation, OMX Ventures, EIFO, and Angelini Ventures. Co-founded in 2020 by CEO Colleen Acosta and CSO Johan van Hylckama Vlieg, the company targets a critical gap in women's health where no approved disease-modifying treatments exist.
Summary
It lists 11–50 employees. It has raised $49.2M in total across 2 rounds, most recently a $11.2M Seed round in Nov 2024. Investors include Bill & Melinda Gates Foundation, Sofinnova Partners and OMX Ventures.
Tech & App Stack
2 technologies & apps tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding History
Nov 2024
Sign up to see all 2 events
Funding: Series A through Seed. Amounts, valuations, and investors where available.
Investors
Similar Companies
China's leading blood products manufacturer
Global contract research organization providing comprehensive drug development and laboratory ser...
Specialty pharmaceutical company
Altos Labs combines academic science and industry development to create medicines that restore ce...
Appears in
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/freya-biosciences"><img src="https://indexed.vc/api/badge/company/freya-biosciences" alt="Freya Biosciences on Indexed.vc" width="260" height="76" /></a>